Wright Medical Dips 11% After FDA's Not Approvable Letter For Augment Bone Graft Shares of Wright Medical Group, Inc. (WMGI) plunged nearly 11 percent in extended trading on Thursday after the orthopedic medical device company received a not approvable letter from the U.S. Food & Drug Administration for its augment bone graft for use as an alternative to autograft in hindfoot and ankle fusion procedures. The FDA issued the letter in response to the company's amended Pre ...
Aug. 9, 2013 - RTT News
NKTR Nearing Results, THLD Progresses, Wright Gets It Wrong, ZGNX On Watch Shares of Wright Medical Group Inc. (WMGI) dropped more than 10 percent to $24.10 in extended trading on Thursday following a not approvable letter from the FDA for the company's Augment Bone Graft for use as an alternative to autograft in hindfoot and ankle fusion procedures.
Aug. 9, 2013 - RTT News